Gene · 64783
Papers2,224
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,224
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RNA m⁶A modification and its regulatory factors are altered in granulosa cells from women with PMOS. | J Assist Reprod Genet | 2026 | 42687053 | PubTator, text mining | PubMed |
| RBM15 in leukemogenesis: an emerging regulator at the interface of RNA biology and hematopoiesis. | Trends Cancer | 2026 | 42680676 | PubTator, text mining | PubMed |
| PTBP1 controls oncogenic transcript processing and maintenance of acute myeloid leukemia. | Leukemia | 2026 | 42637878 | PubTator, text mining | PubMed |
| ZBTB33/RBM15 Axis Upregulates MACC1 to Promote the Malignant Progression of Colorectal Cancer. | Curr Gene Ther | 2026 | 42634545 | PubTator, text mining | PubMed |
| Integrative single-cell transcriptomic and epitranscriptomic analysis of the RBM15-m6A-IL10 regulatory axis in psoriatic keratinocytes. | Front Cell Dev Biol | 2026 | 42614367 | PubTator, text mining | PubMed |
| m6A-dependent regulation of DGUOK-AS1 by RBM15 and HNRNPH1 in lung adenocarcinoma. | iScience | 2026 | 42603931 | PubTator, text mining | PubMed |
| The N6-Methyladenosine-Modified CIT Promotes Uterine Corpus Endometrial Carcinoma Progression by Inhibiting the Hippo Signaling Pathway. | Immunol Cell Biol | 2026 | 42565639 | PubTator, text mining | PubMed |
| Global Phosphoproteome Analysis Identifies CLK4 Co-Regulatory Pathways Driving Tumor-Specific Dysregulation. | OMICS | 2026 | 42484065 | PubTator, text mining | PubMed |
| RBM15 plays a key driving role in the tumorigenesis of EGFR-mutant lung adenocarcinoma and gefitinib resistance. | Sci Rep | 2026 | 42426119 | PubTator, text mining | PubMed |
| RBM15 enhances ILDR1 n6-methyladenosine methylation to accelerate gastric adenocarcinoma progression via an IGF2BP3-dependent manner. | Cytotechnology | 2026 | 42404851 | PubTator, text mining | PubMed |
| Hypoxia-Associated Molecular Subtypes Reveal Immune Checkpoint, Ferroptosis, and m6A Regulatory Heterogeneity in Pediatric Vasculitis. | Hum Mutat | 2026 | 42369204 | PubTator, text mining | PubMed |
| FISH+ is a ready-to-use proximity labeling method for simultaneous RNA visualization and RNA-interacting protein identification. | Commun Biol | 2026 | 42337049 | PubTator, text mining | PubMed |
| RNA helicase DDX5 alleviates UVB-induced skin DNA damage through RBM15/METTL14-mediated m6A modification. | J Photochem Photobiol B | 2026 | 42296715 | PubTator, text mining | PubMed |
| m6A-modified ATF4 regulates glucose/lipid metabolism via the Sestrin2/GSK3β axis to alleviate myocardial ischemia-reperfusion injury. | J Cardiothorac Surg | 2026 | 42286721 | PubTator, text mining | PubMed |
| RBM15 transcription activated by EGR1 stimulates gastric cancer proliferation and metastasis by enhancing m6A modification of RREB1. | Funct Integr Genomics | 2026 | 42213215 | PubTator, text mining | PubMed |
| RBM15/IGF2BP2-PTPRH m6A regulatory axis in non-small cell lung cancer. | Cell Oncol (Dordr) | 2026 | 42113318 | PubTator, text mining | PubMed |
| Nanopore direct RNA sequencing reveals transmissible gastroenteritis virus epitranscriptomic and transcriptomic landscapes modulated by gene 7. | Microb Genom | 2026 | 42053422 | PubTator, text mining | PubMed |
| RBM15 and ZMYND8 shape acute myeloid leukemia response to BCL2 inhibitors. | Haematologica | 2026 | 41988758 | PubTator, text mining | PubMed |
| m6A RNA methylation regulatory gene expression in response to ethanol and acetaldehyde exposure and withdrawal. | Environ Epigenet | 2026 | 41970606 | PubTator, text mining | PubMed |
| Mechanism of RBM15 in the Immune Escape of Non-small Cell Lung Cancer Cells Via the LncRNA EGFR-AS1/USP3/PD-L1 Axis. | Biol Proced Online | 2026 | 41957704 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64783/papers